Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retinal Deep PhenotypingTM by a Novel Mydriatic Hyperspectral Retinal Camera (MHRC) and Analysis by Deep Learning

NCT05903651 is registered in ClinicalTrials.gov with Optina Diagnostics Inc. as lead sponsor.

NCT NCT05903651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05903651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retinal Deep PhenotypingTM by a Novel Mydriatic Hyperspectral Retinal Camera (MHRC) and Analysis by Deep Learning
Lead sponsor
Optina Diagnostics Inc.
Phase
Observational
Overall status
Completed
Start date
April 3, 2023
Completion date
March 14, 2024
Enrollment
813 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy